A corporate partner with extensive international experience, Andrew's clients bring him in to advise on their most complex deals, where negotiating experience and an ability to keep focussed on the points that really matter to his clients are paramount.
M&A, joint ventures and corporate transactions form the core of Andrew's work. He has also handled restructuring transactions (including sales from administration) and for many years he acted for private equity clients and their portfolio companies.
Andrew has advised across a number of sectors, including real estate investment, healthcare, consumer, renewable energy and financial services.
Andrew’s clients and transactions frequently have an international dimension. He has advised on deals in Europe, the Middle East, Asia and North America.
|Since 2021||Partner, Taylor Wessing|
|2011 - 2021||Partner, Stephenson Harwood|
|2000 - 2011||Partner, Weil, Gotshal & Manges|
|1990 - 2000||Associate, Clifford Chance|
|1990||Admitted as a lawyer, England and Wales|
|1988||Legal Practice Course, College of Law|
|1987||Common Professional Examination, College of Law|
Latest news & insights
Silverwood buys £216m Lush stake
Aspen Healthcare sold to Canadian-based property trust
by Andrew McLean and Andrew Edge
The EU Commission's new pharmaceutical package: amended legal framework for data protection, marketing protection and market exclusivity
by Dr. Manja Epping and Sherin Sayed
The EC pharma and patent package – what’s important to know from a patent law perspective?
by multiple authors
Dr. Alfred Fink